Search clinical trials for: Pramipexole ER

Total 848 results

Boehringer Ingelheim

Completed

Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

Parkinson Disease
Boehringer Ingelheim

Completed

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

Parkinson Disease

United States
Areteia Therapeutics

Recruiting

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma (EXHALE-4)

Asthma Attack | Eosinophilic Asthma | Asthma; Eosinophilic

United States, United Kingdom, Romania, Poland
Boehringer Ingelheim

Completed

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
Areteia Therapeutics

Recruiting

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) (EXHALE-3)

Asthma | Eosinophilic Asthma | Asthma; Eosinophilic

United States, South Africa, United Kingdom, Korea, Republic of
Areteia Therapeutics

Recruiting

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. (EXHALE-2)

Asthma | Eosinophilic Asthma | Asthma; Eosinophilic

United States, United Kingdom, Georgia, Romania, Brazil, Bulgaria, Korea, Republic of, Poland, Serbia, Argentina
Region Skane
Lund University

Recruiting

Pramipexole for Anhedonic Depression (PRIME-PRAXOL)

Depression | Anhedonia | Psychiatric Disorders Mood

Sweden
Boehringer Ingelheim

Completed

Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
VA Office of Research and Development
Northwestern University; University of Pittsburgh; San Francisco Veterans Affairs...

Recruiting

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication (MOBILE IC)

Intermittent Claudication

United States
Kissei Pharmaceutical Co., Ltd.

Completed

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

Parkinson Disease

Japan
Boehringer Ingelheim

Completed

Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
Boehringer Ingelheim

Completed

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

Depression | Parkinson Disease

Austria, Finland, France, Germany, Italy, Netherlands, Norway, Romania, Russian Federation, South Africa, Spain, Sweden, Ukraine
Boehringer Ingelheim

Completed

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients

Parkinson Disease

United States
Areteia Therapeutics

Enrolling by invitation

Phase III Long-Term Extension Study With Dexpramipexole (EXHALE-5)

Eosinophilic Asthma

United States
National Institute of Allergy and Infectious Diseases...
Knopp Biosciences

Unknown

Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome

Hypereosinophilic Syndrome

United States
Knopp Biosciences

Completed

Dexpramipexole SAD/MAD Study

Amyotrophic Lateral Sclerosis

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

A Study to Help People Quit Smoking.

Nicotine Dependence

United States
Gwendolyn Sowa

Completed

Effects of Metformin on Low Back Pain

Low Back Pain

United States
Reckitt Benckiser Inc.

Completed

Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers

Healthy Subjects
Supernus Pharmaceuticals, Inc.

Completed

A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)

Epilepsy

United States
Adamas Pharmaceuticals, Inc.

Terminated

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID (ALLAY-LID-II)

Parkinson's Disease | Levodopa Induced Dyskinesia (LID)

France, Germany, Canada, United States, Spain
Brigham and Women's Hospital
National Institute of Mental Health (NIMH); Northwell Health; Icahn School of... and other collaborators

Completed

Targeting Cognition in Bipolar Disorder With Pramipexole (PRAM-BD)

Bipolar Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH); Columbia University; Icahn School... and other collaborators

Completed

Imaging Dopamine Release in Depression

Major Depressive Disorder

United States
Boehringer Ingelheim

Completed

Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

Parkinson Disease
Boehringer Ingelheim

Completed

Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
James Wang
United States Department of Defense

Recruiting

Managing Chronic Tendon Pain by Metformin

Chronic Pain | Tendinopathy | Achilles Tendinopathy

United States
Laboratorios Silanes S.A. de C.V.

Completed

Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)

Healthy

Mexico
Janssen Korea, Ltd., Korea

Completed

A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition

Healthy

Korea, Republic of
Mylan Pharmaceuticals Inc

Completed

Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg

Healthy

United States
Yuzuncu Yıl University

Completed

Er,Cr:YSGG Laser Application in Peri-implantitis

Peri-Implantitis

Turkey
National Cancer Institute (NCI)

Completed

E7389 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance

Restless Legs Syndrome

United States
Palo Alto Veterans Institute for Research
National Institute of Mental Health (NIMH)

Completed

Treatment of Mania Symptoms With Drug Therapy

Schizophrenia | Bipolar Disorder

United States
Mylan Pharmaceuticals Inc

Completed

Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg

Healthy

United States
M.D. Anderson Cancer Center

Terminated

Metformin in Non Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
Acorda Therapeutics

Completed

Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment

Renal Insufficiency

United States
Teva Pharmaceuticals USA

Completed

Metformin ER 750 mg Tablets, Fed

Healthy

Canada
Knopp Biosciences

Completed

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211) (CL211)

Amyotrophic Lateral Sclerosis

United States
National Institute of Mental Health (NIMH)

Completed

Clinical Trial of Pramipexole in Bipolar Depression

Bipolar Disorder

United States
Knopp Biosciences

Completed

Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study

Healthy Volunteers

United States
Boehringer Ingelheim

Completed

The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia

Heart Failure
Impax Laboratories, LLC

Completed

A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis

Multiple Sclerosis | Spasticity

United States
Lina Bergman
The Swedish Research Council

Recruiting

PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia (PI4)

Preeclampsia

Sweden
E-DA Hospital

Recruiting

Naldebain for Pain Control After Bariatric Surgery

Obesity | Pain, Postoperative | Pharmacokinetics | Pain, Chronic | Bariatric Surgery

Taiwan
Haukeland University Hospital

Recruiting

Biomarker Guided Treatment in Gynaecological Cancer (Momatec2)

Endometrial Cancer

Norway, Netherlands, Poland
Mylan Pharmaceuticals Inc

Completed

Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg

Healthy

United States
Woman's
Pfizer; American Cancer Society, Inc.; Our Lady of the Lake Regional Medical...

Withdrawn

Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer (METBC)

Insulin Resistance | Breast Cancer Stage | Racial Bias

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 25-mg Tablets Relative to One 50-mg Tablet

Healthy Volunteer
Boehringer Ingelheim

Completed

Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease

Parkinson Disease
Second Affiliated Hospital, School of Medicine,...

Recruiting

Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia

Androgenetic Alopecia

China

Search clinical trials for: Pramipexole ER

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations